Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort

Autor: Anders Tidblad, Muriel Thomas, Lars Sävendahl, Christa E. Flück, Dominique Beckers, Peter E. Clayton, Aysha J. Khan, Joël Coste, Stefano Cianfarani, Annalisa Deodati, Jean-Claude Carel, Roland Pfäffle, Sally Tollerfield, Gladys R J Zandwijken, Emmanuel Ecosse, Grit Sommer, Anita C. S. Hokken-Koelega, Gary Butler, Claudia E. Kuehni, Anthony J. Swerdlow, Rosie Cooke, Wieland Kiess

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 104(3), 658-664. Endocrine Society
Clayton, P, Khan, A & et al. 2018, ' Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort ', The Journal of Clinical Endocrinology and Metabolism . https://doi.org/10.1210/jc.2018-01133
Swerdlow, Anthony J; Cooke, Rosie; Beckers, Dominique; Butler, Gary; Carel, Jean-Claude; Cianfarani, Stefano; Clayton, Peter; Coste, Joël; Deodati, Annalisa; Ecosse, Emmanuel; Hokken-Koelega, Anita C S; Khan, Aysha J; Kiess, Wieland; Kuehni, Claudia E; Flück Pandey, Christa Emma; Pfaffle, Roland; Sävendahl, Lars; Sommer, Grit; Thomas, Muriel; Tidblad, Anders; ... (2019). Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort. Journal of clinical endocrinology and metabolism, 104(3), pp. 658-664. Endocrine Society 10.1210/jc.2018-01133
The Journal of Clinical Endocrinology and Metabolism

Context There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited. Objective To examine meningioma risks in relation to GH treatment. Design Cohort study with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666cb641850c2776b5ef6e0f3cd1aed4
https://doi.org/10.1210/jc.2018-01133

Phenotypic Features and Response to GH Treatment of Patients With a Molecular Defect of the IGF-1 Receptor

Autor: M.J.E. Walenkamp, Hermine A van Duyvenvoorde, Jasmijn M L Robers, Jan M. Wit, Gladys R J Zandwijken, Monique Losekoot, Sarina G. Kant, Anita C. S. Hokken-Koelega, Wilma Oostdijk

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 104(8), 3157-3171. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 104(8), 3157-3171. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 104(8), 3157-3171. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 104(8), 3157-3171
Walenkamp, M J E, Robers, J M L, Wit, J M, Zandwijken, G R J, van Duyvenvoorde, H A, Oostdijk, W, Hokken-Koelega, A C S, Kant, S G & Losekoot, M 2019, ' Phenotypic Features and Response to GH Treatment of Patients with a Molecular Defect of the IGF-1 Receptor ', Journal of Clinical Endocrinology and Metabolism, vol. 104, no. 8, pp. 3157-3171 . https://doi.org/10.1210/jc.2018-02065

Context: The phenotype and response to GH treatment of children with an IGF1R defect is insufficiently known. Objective: To develop a clinical score for selecting children with short stature for genetic testing and evaluate the efficacy of treatment.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17530b75a87e67e3b82187faffe5c82
https://hdl.handle.net/1887/120860

Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment

Autor: Jenny A. Visser, Andreas Limacher, Gladys R J Zandwijken, Michael B. Ranke, Anita Hokken-Koelega, Christa E. Flück

Publikováno v: Visser, Jenny A.; Hokken-Koelega, Anita C. S.; Zandwijken, Gladys R. J.; Limacher, Andreas; Ranke, Michael B.; Flück, Christa E. (2013). Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Human reproduction, 28(7), pp. 1899-1907. Oxford: Oxford University Press 10.1093/humrep/det089
Human Reproduction, 28(7), 1899-1907. Oxford University Press

STUDY QUESTION In girls and adolescents with Turner syndrome (TS), is there a correlation between serum AMH levels and karyotype, spontaneous puberty and other biochemical markers of ovarian function, or growth hormone (GH) therapy? SUMMARY ANSWER Se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9a72499372aa168a0574f98d9569d8
https://doi.org/10.1093/humrep/det089

Long-term mortality and causes of death in isolated GHD, ISS and SGA patients treated with Recombinant Growth Hormone during childhood in Belgium, The Netherlands and Sweden: Preliminary report of 3 countries participating in the EU SAGhE Studdy

Autor: Gladys R J Zandwijken, Marc Maes, Birgit Borgström, Jean-Claude Carel, Anita C. S. Hokken-Koelega, Muriel Thomas, Séverine Henrard, Lars Sävendahl, Kerstin Albertsson-Wikland, Niko Speybroeck

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 97(2), E213-E217. Endocrine Society

CONTEXT: The long-term mortality in adults treated with recombinant GH during childhood has been poorly investigated. Recently released data from the French part of the European Union Safety and Appropriateness of GH treatments in Europe (EU SAGhE) s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a09887a927e9867fed7fc1a3a1a6f4a1
https://pure.eur.nl/en/publications/cb8d58dc-4fe6-4380-a26c-d349d23bd1aa

Towards evidence based referral criteria for growth monitoring

Autor: S. van Buuren, Gladys R J Zandwijken, P. van Dommelen, Jan M. Wit, F K Grote, P.H. Verkerk

Publikováno v: Archives of Disease in Childhood, 4, 89, 336-341

Aims: To evaluate the performance of growth monitoring in detecting diseases. Turner’s syndrome (TS) is taken as the target disease. Methods: Case-control simulation study. Three archetypal screening rules are applied to longitudinal growth data co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051b53223689415ed402a50ec11f032c
https://doi.org/10.1136/adc.2003.027839